Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients
From PeerView Clinical Pharmacology CME/CNE/CPE Video by PVI, PeerView Institute for Medical Education
May 29, 2026 · 49 min
About this episode
The episode discusses achieving durable asparaginase exposure through personalized treatment strategies for pediatric and AYA patients with ALL/LBL.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CQN865. CME/AAPA/IPCE credit will be available until June 21, 2027. ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This program is supported by an independent medical education grant from Jazz Pharmaceuticals. Disclosure information is available at the beginning of the video presentation.
People in this episode
Guests: Luke Maese, DO, Rachel Rau, MD
Topics covered
- Asparaginase Exposure
- Personalized Treatment
- Pediatric Oncology
- Acute Lymphoblastic Leukemia
- Adolescent and Young Adult Patients
Keywords
- Asparaginase
- Pediatric Patients
- AYA Patients
- ALL
- LBL
- Personalized Treatment
- CME
- Medical Education
Sponsors
Jazz Pharmaceuticals
Mentioned in this episode
Organizations: PVI, PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Nurses Credentialing Center (ANCC)
More episodes of PeerView Clinical Pharmacology CME/CNE/CPE Video
- Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes · June 5, 2026 · 32 min
- Brendon M. Stiles, MD - The Immunotherapy Playbook for Resectable NSCLC: Real-World Challenges and Practical Strategies · June 4, 2026 · 1h 6m
- Charise Gleason, MSN, NP-C, AOCNP / Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - “Off-the-Shelf” Choices in RRMM: Oncology Nurse Guidance on Delivering Quality Care With BCMA and Non-BCMA Immunotherapy · May 29, 2026 · 60 min
- Anna Chodos, MD, MPH - Getting Ahead of Cognitive Decline—Applying Patient-Centered Strategies to Assess and Reduce Dementia Risk in Primary Care: An AI-Guided Case Simulation Activity · May 29, 2026 · 46 min
- Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution · May 29, 2026 · 55 min
- Anita Afzali, MD, MPH, MHCM, FACG, AGAF / Jessica R. Allegretti, MD, MPH, FACG, AGAF / Millie D. Long, MD, MPH - At the Crossroads of Inflammation and Fibrosis in Inflammatory Bowel Disease: The Promise of TL1A Inhibition · May 29, 2026 · 1h 11m
Explore listener stats, chart rankings, contacts and more on the PeerView Clinical Pharmacology CME/CNE/CPE Video podcast page.